ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000224855.1	AKT inhibitor VIII	Bladder urothelial carcinoma	0.023415454	Resistant
ENSG00000224855.1	AKT inhibitor VIII	Thyroid carcinoma	0.015327686	Sensitive